$75.99Original price was: $75.99.$65.99Current price is: $65.99.
Out of stock
Out of stock
Guaranteed Safe Checkout
>99% Purity | Third-Party Tested
RESEARCH USE ONLY
This product is for R&D purposes only and is not approved for human or veterinary use.
CJC-1295 (No DAC) 5mg + Ipamorelin 5mg
CJC-1295 (No DAC) + Ipamorelin (research peptide blend) is a combination peptide formulation supplied for use in qualified laboratory and institutional research settings. This product is intended strictly for research purposes only and is commonly used in experimental studies exploring growth-hormone–related signaling pathways, receptor interactions, and endocrine physiology under controlled conditions.
Research Context
CJC-1295 (No DAC) is a synthetic peptide analog studied in research contexts for its interaction with growth hormone–releasing hormone (GHRH) receptor signaling. Ipamorelin is a synthetic peptide commonly examined for its interaction with ghrelin-related receptor pathways (often studied within growth hormone secretagogue research). In preclinical and translational research, these pathways are investigated for their roles in pulsatile endocrine signaling, downstream biomarker responses, and mechanistic models relevant to pituitary-axis regulation. Combination use in laboratory research may support comparative pathway evaluation and characterization of signaling dynamics in controlled systems.
Research Overview
This blend is formulated to support controlled investigation of receptor-mediated signaling and downstream response markers in vitro and in vivo. Researchers may utilize CJC-1295 (No DAC) + Ipamorelin in cell-based assays, receptor activation studies, and experimental animal models to examine endocrine signaling mechanisms, timing-dependent response patterns, and pharmacological profiling within approved research protocols.
Key Research Focus Areas
Endocrine Signaling Pathways: Investigating growth-hormone–related signaling cascades and downstream biomarker response patterns in controlled models.
Receptor Interaction Studies: Exploring receptor binding and activation dynamics associated with GHRH- and ghrelin-related pathways.
Pharmacology & Profiling: Assessing potency, response timing, stability, and comparative activity across experimental systems.
Comparative Research: Evaluating combination signaling behavior alongside individual peptides or related analogs in mechanistic studies.
Product Specifications
Compound Name
CJC-1295 (No DAC) 5mg + Ipamorelin 5mg
Purity
≥ 99% (HPLC verified)
Molecular Classification
Synthetic peptide blend (GHRH analog + growth hormone secretagogue research peptide)
Physical Form
Lyophilized (freeze-dried) powder
Net Content
10mg total per sterile glass vial (5mg + 5mg)
Vial Material
Borosilicate laboratory-grade glass
Appearance
White to off-white solid
Storage Conditions
Store refrigerated at 2–8°C. Protect from light and moisture.
Intended Use
For laboratory research use only. Not for human or veterinary use.
Analytical verification documentation may be available upon request for qualified research institutions.
This peptide blend is provided in a research-grade formulation intended to support stability, consistency, and reproducibility in laboratory workflows. Researchers should follow institutional safety standards, ethical protocols, and approved handling procedures when conducting experiments involving peptide combinations.
For research use only. Not for human or animal consumption.
This product is currently undergoing third-party batch testing at our U.S.-based laboratory. The Certificate of Analysis will be published here once verification is complete.
COAs are typically available within a few business days of a new batch release.